Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

51 views
Visitors fromUSUS 54%·AUAU 32%·ININ 7%·GBGB 2%·FRFR 2%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

The Assistance Fund Opens New Program for Focal Segmental Glomerulosclerosis (FSGS)

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Focal Segmental Glomerulosclerosis (FSGS)

ORLANDO, FL / ACCESS Newswire / May 18, 2026 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with focal segmental glomerulosclerosis (FSGS). The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses.

Focal segmental glomerulosclerosis (FSGS) is a kidney disease in which scar tissue forms in the glomeruli, the tiny filters that remove waste from the blood, impairing kidney function. It can result from a variety of causes, such as other health conditions, infections, toxins, and genetic factors. If left untreated, FSGS can lead to serious complications, including nephrotic syndrome and kidney failure.1

"For people living with focal segmental glomerulosclerosis, timely and consistent treatment can slow disease progression and improve outcomes," said Danielle Vizcaino, President and CEO of The Assistance Fund. "Thanks to our generous donors, we're proud to launch our FSGS Financial Assistance Program to expand access to critical treatment."

To learn more or determine eligibility for financial support, visit tafcares.org or call (844) 776-9631 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages over 100 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped over 260,000 children and adults access the treatment they need to stay healthy or manage a life-changing disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley
Senior Director of Communications
Communications@tafcares.org

1 Mayo Clinic, "Focal Segmental Glomerulosclerosis (FSGS)," https://www.mayoclinic.org/diseases-conditions/fsgs/symptoms-causes/syc-20354693, accessed December 2025.

SOURCE: The Assistance Fund (TAF)



View the original press release on ACCESS Newswire

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.32
+0.00 (0.00%)
AAPL  308.82
+0.00 (0.00%)
AMD  467.51
+0.00 (0.00%)
BAC  51.80
+0.00 (0.00%)
GOOG  379.38
+0.00 (0.00%)
META  610.26
+0.00 (0.00%)
MSFT  418.57
+0.00 (0.00%)
NVDA  215.33
+0.00 (0.00%)
ORCL  192.08
+0.00 (0.00%)
TSLA  426.01
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.